| Feature | Specification |
|---|---|
| Application | 新生児スクリーニング |
These types represent 95% of CAH cases and in both, the 17α-OH progesterone (17OHP), a precursor of cortisol, is increased. The determination of 17OHP is thus a useful screening method for 95% of all CAH cases.
GSP Neonatal 17α-OH-progesterone assay
The GSP Neonatal 17α-OH-progesterone assay is intended for the quantitative determination of 17OHP in dried blood spot specimens as an aid in screening newborns for CAH.
| Application |
Newborn Screening
|
|---|---|
| Brand |
GSP®
|
| Detection Modality |
Time-Resolved Fluorescence (TRF)
|
| Disorders |
Congenital Adrenal Hyperplasia (CAH)
|
| Instrument Compatibility |
GSP
|
| Quantity |
1152 tests
|
| Regulatory Status |
CE-IVD marked
|
| Sample Type |
Dried blood spots
|
| Technology |
DELFIA
|
| Unit Size |
12 plates
|
Are you looking for resources, click on the resource type to explore further.
We are here to answer your questions.